# Use of UC-MSCs for COVID-19 Patients

> **NCT04355728** · PHASE1,PHASE2 · COMPLETED · sponsor: **Camillo Ricordi** · enrollment: 24 (actual)

## Conditions studied

- Corona Virus Infection
- ARDS
- ARDS, Human
- Acute Respiratory Distress Syndrome
- COVID-19

## Interventions

- **BIOLOGICAL:** Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.
- **OTHER:** Vehicle + Heparin along with best supportive care

## Key facts

- **NCT ID:** NCT04355728
- **Lead sponsor:** Camillo Ricordi
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-25
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355728, "Use of UC-MSCs for COVID-19 Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04355728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*